Novartiss $48,000 Pill Spurs U.S. Price Increases for MS Drugs

March 22 (Bloomberg) -- The prices of multiple sclerosis medicines have risen as much as 39 percent since last year, even as competition intensified with the introduction of the first pill to treat the disease. Teva Pharmaceutical Industries...